The lifetime risk of developing bipolar II disorder is 5-7%, yet the condition is often poorly detected. Mood elevation states are less extreme than in bipolar I disorder although the depressive episodes are usually severe. When correctly treated, the outcome is positive, but bipolar II is often poorly managed, resulting in a high suicide rate. This is the only academic and clinical management review focused entirely on bipolar II, scrutinizing history, epidemiology, burden and neurobiology and including an extensive clinical debate by international experts about effective management strategies. Now in its third edition, this book features new chapters on the limitations to clinical treatment trials and perinatal management nuances. In a completely new section, international experts offer their personal responses and distinctive wisdom to key management issues and allow the reader to observe a variety of opinions.

Now in its third edition, this book is the only academic and clinical management review focusing on bipolar II disorder.

About the Author
Gordon Parker is currently Scientia Professor of Psychiatry, University of New South Wales, Sydney, and was Executive Director of the Black Dog Institute from 2002 to 2011. He was, for nearly two decades, Head of the School of Psychiatry at the University of New South Wales and Director of the Division of Psychiatry at the Prince of Wales and Prince Henry Hospitals, and was part-time Research Director of the Institute of Mental Health in Singapore.


Book Information
ISBN 9781108414111
Author Gordon Parker
Format Paperback
Page Count 318
Imprint Cambridge University Press
Publisher Cambridge University Press
Weight(grams) 560g
Dimensions(mm) 234mm * 156mm * 16mm